In particular, genetically altered mouse models of atherosclerosis including the apolipoprotein E-deficient (Apoe−/−) [12] and low-density lipoprotein receptor-deficient (Ldlr−/−) mice [13] have substantially contributed to the development of the atherosclerosis research field. This evidence concerns the gene APOE and atherosclerosis.